Search for: "Mylan Pharmaceuticals" Results 261 - 280 of 739
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2008, 9:35 pm
Generic drug maker Mylan got some good news from the U.S. [read post]
21 Dec 2016, 7:18 am by Gene Quinn
Mylan Pharmaceutical Inc. says they expect PTAB decisions on the IPRs sometime during the fourth quarter of 2017. [read post]
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
31 Jul 2020, 9:40 am by Lawrence B. Ebert
For the reasons described below, we affirm.The matters at issue:In 2016, Takeda sued Mylan Pharmaceuticals Inc. forpatent infringement based on Mylan’s recently submittedAbbreviated New Drug Application (“ANDA”) for a genericversion of Takeda’s Colcrys® product, which is a brandedversion of the drug colchicine. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Mylan Pharmaceuticals Inc., Mylan, Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
22 Oct 2009, 7:17 am by fraudfighters
Department of Justice announced that Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals, and Ortho McNeil Pharmaceutical agreed to pay a combined $124 million to settle a civil lawsuit under the False Claims Act alleging that the companies engaged in fraud in connection with Medicaid rebates. [read post]
1 Nov 2020, 4:35 am by Magdaleen Jooste
The District Court in the Hague made a ruling in the case between Novartis and Mylan, concerning the pharmaceutical Exjade, which is protected by both a patent and subsequently a Supplementary Protection Certificate as well by an Orphan Drug Designation. [read post]
6 Sep 2016, 3:30 pm by Kathryn Rubino
[Perez Hilton] * EpiPen's maker, Mylan Pharmaceuticals, is in more hot water. [read post]
15 Nov 2018, 10:21 am by Christopher Hsu
The case involved secondary usage of a known and patented pharmaceutical compound—applying an already patented pharmaceutical compound to a new use. [read post]
24 Jul 2008, 5:15 pm
The product is made by Totowa LLC and distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc., under a “UDL” label. [read post]
16 May 2008, 11:03 am
Digitek is manufactured by Icelandic generic drug-maker Actavis Totowa; it is distributed by Mylan Pharmaceuticals under the label "Bertek and by UDL Laboratories under the label "UDL. [read post]
16 May 2008, 11:03 am
Digitek is manufactured by Icelandic generic drug-maker Actavis Totowa; it is distributed by Mylan Pharmaceuticals under the label "Bertek and by UDL Laboratories under the label "UDL. [read post]
17 Nov 2020, 9:16 pm by Rik Lambers (Brinkhof)
To almost finish a long post with a long sentence, one fact from that case: in view of the earlier cross-border case law that a Dutch MA holder also acts unlawful if a foreign entity, holding a pharmaceutical authorization, infringes with a generic product, Teva decided that the MA and pharmaceutical authorization should be held by the same entity within the group. [read post]